跳转至内容
Merck

F5557

Sigma-Aldrich

Fasentin

≥98% (HPLC)

别名:

N-[4-氯-3-(三氟甲基)苯基]-3-氧代丁酰胺

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C11H9ClF3NO2
分子量:
279.64
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

white to off-white

溶解度

DMSO: >10 mg/mL

儲存溫度

room temp

SMILES 字串

CC(=O)CC(=O)Nc1ccc(Cl)c(c1)C(F)(F)F

InChI

1S/C11H9ClF3NO2/c1-6(17)4-10(18)16-7-2-3-9(12)8(5-7)11(13,14)15/h2-3,5H,4H2,1H3,(H,16,18)

InChI 密鑰

GNYIJZMBLZXJEJ-UHFFFAOYSA-N

應用

Fasentin已被用作葡萄糖转运蛋白(GLUT1)抑制剂,用于评估其对各种三阴性乳腺癌 (TNBC) 细胞系脆弱性的影响,并研究其对氢化可的松(HC)诱发的细胞毒性药物的作用。

生化/生理作用

Fastentin是一种葡萄糖摄入的全新抑制剂,GluT1抑制剂。Fastentin是一种全新的葡萄糖摄入抑制剂,可敏化细胞对FAS诱导的细胞死亡。Fastentin会选择性敏化死亡配体,但不会降低FLIP的表达。它会改变与营养和葡萄糖剥夺相关的基因表达。Fastentin可与葡萄糖转运蛋白GLUT1细胞间通道中一个独特的位点发生互作。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Eleni Louka et al.
The Journal of experimental medicine, 218(2) (2021-01-09)
Juvenile myelomonocytic leukemia (JMML) is a poor-prognosis childhood leukemia usually caused by RAS-pathway mutations. The cellular hierarchy in JMML is poorly characterized, including the identity of leukemia stem cells (LSCs). FACS and single-cell RNA sequencing reveal marked heterogeneity of JMML
Dominik Kraus et al.
Cellular and molecular life sciences : CMLS, 73(6), 1287-1299 (2015-09-27)
In our study, ghrelin was investigated with respect to its capacity on proliferative effects and molecular correlations on oral tumor cells. The presence of all molecular components of the ghrelin system, i.e., ghrelin and its receptors, was analyzed and could
Qin Wu et al.
Nature communications, 11(1), 4205-4205 (2020-08-23)
Triple negative breast cancer (TNBC) is a deadly form of breast cancer due to the development of resistance to chemotherapy affecting over 30% of patients. New therapeutics and companion biomarkers are urgently needed. Recognizing the elevated expression of glucose transporter

商品

We presents an article about the Warburg effect, and how it is the enhanced conversion of glucose to lactate observed in tumor cells, even in the presence of normal levels of oxygen. Otto Heinrich Warburg demonstrated in 1924 that cancer cells show an increased dependence on glycolysis to meet their energy needs, regardless of whether they were well-oxygenated or not.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门